Suciadi Leonardo P, Wibawa Kevin, Jessica Giovanni, Henrina Joshua, Cahyadi Irvan, Santi Bryany T, Hariadi Titus K, Tedjasukmana Firman, Kristanti Nathania M, Pakpahan Elisa F, Manullang Reynold A, Sutandar Antono
Cardiology, Siloam Heart Institute/Siloam Hospitals Kebon Jeruk, Jakarta, IDN.
Research, Siloam Heart Institute, Jakarta, IDN.
Cureus. 2021 Jun 21;13(6):e15802. doi: 10.7759/cureus.15802. eCollection 2021 Jun.
This study aimed to assess the factors contributing to the outcomes of recently hospitalized patients with heart failure (HF).
A prospective data of 76 adults who were admitted due to acute HF between October 1, 2019 and June 30, 2020 at our center were analyzed. Endpoints included survival and rehospitalization within six months after discharge.
The mean age was 64.9 ± 13.8 years, with a male preponderance (68.4%). Approximately 60.5% of patients had the left ventricular ejection fraction (LVEF) <40%, whereas 26.3% of patients had LVEF ≥50%. Coronary artery disease (75%), arterial hypertension (72.4%), chronic kidney disease (46.1%), and diabetes mellitus (46.1%) were the most frequent comorbidities. Poor compliance (40.8%) and non-cardiac infection (21.1%) were the common precipitating factors for hospitalization. The majority of subjects had severe symptoms, indicated by the frequent need of intensive care unit (43%), high N-terminal prohormone brain natriuretic peptide levels [NT-proBNP; median, 4765 (1539.7-11782.2) pg/mL], and presence of either atrial fibrillation, severe mitral regurgitation, or significant pulmonary hypertension in approximately one-third of cases. Even though in-hospital mortality was relatively low (2.6%), the all-cause mortality and rehospitalization rates in the next six months after discharge were still high, reaching 22.54% and 19.72%, respectively. Further survival analysis showed that tachycardia on admission and pre-existing chronic kidney disease (CKD) resulted in low six-month survival rates among these patients.
After hospital discharge, patients with HF were still exposed to higher risks of death and readmission albeit with the medication addressed. Tachycardia on admission and pre-existing CKD might predict worse outcomes.
本研究旨在评估影响近期住院心力衰竭(HF)患者预后的因素。
分析了2019年10月1日至2020年6月30日期间在本中心因急性HF入院的76例成人患者的前瞻性数据。终点指标包括出院后六个月内的生存率和再住院率。
平均年龄为64.9±13.8岁,男性占优势(68.4%)。约60.5%的患者左心室射血分数(LVEF)<40%,而26.3%的患者LVEF≥50%。冠状动脉疾病(75%)、动脉高血压(72.4%)、慢性肾脏病(46.1%)和糖尿病(46.1%)是最常见的合并症。依从性差(40.8%)和非心脏感染(21.1%)是住院的常见诱发因素。大多数受试者有严重症状,表现为频繁需要重症监护病房(43%)、高N末端脑钠肽前体水平[NT-proBNP;中位数,4765(1539.7-11782.2)pg/mL],约三分之一的病例存在心房颤动、严重二尖瓣反流或显著肺动脉高压。尽管住院死亡率相对较低(2.6%),但出院后接下来六个月的全因死亡率和再住院率仍然很高,分别达到22.54%和19.72%。进一步的生存分析表明,入院时心动过速和既往存在的慢性肾脏病(CKD)导致这些患者六个月生存率较低。
出院后,尽管进行了药物治疗,HF患者仍面临较高的死亡和再入院风险。入院时心动过速和既往存在的CKD可能预示预后较差。